Adolescent Fibromyalgia Study
| Status: | Completed |
|---|---|
| Conditions: | Fibromyalgia, Pain |
| Therapuetic Areas: | Musculoskeletal, Rheumatology |
| Healthy: | No |
| Age Range: | 12 - 17 |
| Updated: | 11/8/2014 |
| Start Date: | May 2010 |
| End Date: | April 2015 |
| Contact: | Pfizer CT.gov Call Center |
| Phone: | 1-800-718-1021 |
A 15 Week, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
This study will compare pregabalin with placebo over a 15 week period in adolescents with
fibromyalgia aged 12-17 years to evaluate the safety and efficacy of pregabalin.
fibromyalgia aged 12-17 years to evaluate the safety and efficacy of pregabalin.
Inclusion Criteria:
- Diagnosis of fibromyalgia
- 12-17 years of age
Exclusion Criteria:
- Patients with other pain conditions
- Previous treatment with pregabalin
- Patients taking excluded medication
We found this trial at
22
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials